医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Global and China Insulin Market to Reach US$32.24 Billion by 2019: Transparency Market Research

2014年11月25日 PM09:14
このエントリーをはてなブックマークに追加


 

ALBANY, New York

Transparency Market Research has recently added a latest report titled as “Global and China Insulin Market - Industry Analysis, Size, Share, Growth, Trends and Forecast (Value and Volume), 2013 – 2019” to its market research report database.

Diabetes is growing as a serious health concern in China, as well as other parts of the world at an exponential rate, due to which the insulin industry has been witnessing continuous growth, innovations and advancements with different insulin derivatives on the market.

Browse report: http://www.transparencymarketresearch.com/insulin-market.html

The report focuses on identifying various market scenarios of the current, as well as the future market potential for insulin globally. The report also analyzes and thoroughly studies the overview of the insulin market in China. The insulin market is segmented based on two vital aspects: by source and by mode of action. However, the global and China insulin market is further categorized based on long-acting insulin, short-acting insulin, fast-acting insulin, premixed insulin and intermediate-acting insulin.

Based on various observations, market studies, detailed qualitative analysis of the factors responsible for driving and posing challenges in the global and China insulin market, the overall research report is designed to highlight the focus on insulin and its benefits in the markets.

Request Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=259

Future opportunities and major players along with recent developments in the global and China insulin market have also been discussed in the market overview and competitive sections. Novo Nordisk, Shanghai Fosun Pharmaceuticals, Sanofi, and Eli Lilly and Company are some of the names profiled in the study of the global and China insulin market report.

Press Release: http://www.transparencymarketresearch.com/pressrelease/insulin-market.htm

About Us

Transparency Market Research (TMR) is a U.S. based market intelligence company driven by a global team of high-pedigree industry consultants, analysts, and researchers. TMR leverages its worldwide Syndicated Research, Custom Research, and Market Consulting expertise to help businesses make accurate decisions.

The company’s multi-disciplinary expertise has made it the preferred growth partner of hundreds of companies worldwide, from multibillion dollar conglomerates to emerging regional businesses. TMR’s exclusive blend of quantitative forecasting and trends analysis draws on proprietary data sources, tools, and techniques. TMR’s data repository is continuously updated by a team of research experts, so it always reflects latest trends and information.

CONTACT

Transparency Market Research
Ms. Sheela AK, +1-518-618-1030
USA-Canada
Toll Free: 866-552-3453
sales@transparencymarketresearch.com
http://www.transparencymarketresearch.com/

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Brightree发布面向居家医疗器械的首个患者App
  • Brightreeが初のHME向け患者アプリを発表
  • Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
  • ポットネットワーク・ホールディングスがSEC報告会社登録に基づきPCAOB監査人による完全な監査・レビュー済みの財務報告書を公表
  • Takeda Receives Clearance from the Japan Fair Trade Commission for the Proposed Acquisition of Shire plc